WHO ICTRP trial
Manjishtha mulethi lep application on long bones fractures
CTRI/2022/02/040231 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/02/040231 |
|---|---|
| Public title | Manjishtha mulethi lep application on long bones fractures |
| Scientific title | "Randomized Controlled Trial of Manjishthamulethi Lepa on Kandabhagna With Special Reference to Undisplaced Fracture of Upper Extremities" |
| Primary sponsor | Gangadhar katore |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: S424- Fracture of lower end of humerus |
| Registration date | Nov 2, 2022 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: